Approval Launch

Category
Continent
From
To
 
Lupin Receives Tentative Approval from U.S. FDA fo...

Lupin Receives Tentative Approval from U.S. FDA fo...

Category : Approval/Launch 19 May 2026

Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (B...
Liavium®-CA1 (pregabalin chewable tablets) Receive...

Liavium®-CA1 (pregabalin chewable tablets) Receive...

Category : Approval/Launch 19 May 2026

Pegasus Laboratories, Inc. (Pegasus), under its registered trademark PRN® Pharmacal brand, today...
Eli Lilly Launches Alzheimer’s Drug Lormalzi (Dona...

Eli Lilly Launches Alzheimer’s Drug Lormalzi (Dona...

Category : Approval/Launch 14 May 2026

Eli Lilly and Company has officially launched Lormalzi (donanemab) in India following marketing auth...
FDA Expands Asceniv Label to Include Pediatric Pat...

FDA Expands Asceniv Label to Include Pediatric Pat...

Category : Approval/Launch 6 May 2026

For companies operating in niche biologics, label expansion is often more valuable than new approval...
Novartis Secures EU Approval for Rhapsido: A New O...

Novartis Secures EU Approval for Rhapsido: A New O...

Category : Approval/Launch 28 April 2026

The treatment landscape for chronic spontaneous urticaria (CSU) just shifted. Novartis has secured E...

Categories

Latest Newsletter Post

Subscribe to Our Newsletter!

Subscribe to get latest updates and information.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!